×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| ZENOTECH LABORATORIES LTD. | 116.14 | 16.93 | 102.22 | 0.28 | 356.0 | 91.8 |
| SMS Lifesciences India Ltd | 846.58 | 48.53 | 846.01 | 18.08 | 356 | 16.9 |
| AMBALAL SARABHAI ENTERPRISES L | 515.80 | 22.32 | 459.71 | 0.29 | 329 | 23.2 |
Zenotech Laboratories Limited, with Security Code 532039, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.2 | 7.7 | 9.9 | 8.2 | 10.5 | 10.9 | 8.0 | 9.9 | 8.7 | 10.2 |
| Expenses | 5.3 | 5.2 | 5.9 | 5.6 | 6.0 | 5.7 | 6.3 | 6.5 | 7.4 | 7.4 |
| Operating Profit | 4.0 | 2.6 | 4.0 | 2.7 | 4.5 | 5.3 | 1.8 | 3.4 | 1.4 | 2.9 |
| OPM % | 43.03% | 32.84% | 40.36% | 32.17% | 42.77% | 48.1% | 21.78% | 34.66% | 15.86% | 27.91% |
| Other Income | 1.7 | 1.2 | 1.2 | 1.2 | 1.2 | 0.3 | 1.3 | 0.3 | 2.7 | 2.0 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.7 | 1.7 | 1.7 | 1.7 | 1.8 |
| Profit before tax | 3.9 | 1.9 | 3.5 | 2.1 | 3.9 | 3.8 | 1.4 | 2.0 | 1.0 | 2.5 |
| Tax % | 28.2% | 28.4% | 5.3% | 30.1% | 27.4% | 11.6% | 51.9% | 37% | 42.7% | 45.5% |
| Net Profit | 2.8 | 1.4 | 3.7 | 1.4 | 2.8 | 3.4 | 0.7 | 1.3 | 1.3 | 1.7 |
| EPS in Rs | 0.45 | 0.23 | 0.6 | 0.24 | 0.46 | 0.55 | 0.11 | 0.21 | 0.22 | 0.28 |
| Metrics |
|---|
| Sales |
| Expenses |
| Operating Profit |
| OPM % |
| Other Income |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| Net Profit |
| EPS in Rs |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 26% |
| 3 Years: | 22% |
| TTM: | -6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 36% |
| 3 Years: | 107% |
| TTM: | -66% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 17% |
| 3 Years: | 6% |
| 1 Year: | -20% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -20% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 17% |
| 3 Years: | 6% |
| 1 Year: | -20% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|